|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61P 5/02 | |||
| A61K 9/00 |
| (11) | Number of the document | 1830806 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05804975.0 |
| Date of filing the European patent application | 2005-12-20 | |
| (97) | Date of publication of the European application | 2007-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/013703 |
| Date | 2005-12-20 |
| (87) | Number | WO 2006/066868 |
| Date | 2006-06-29 |
| (30) | Number | Date | Country code |
| 0428151 | 2004-12-22 | GB |
| (72) |
LAMBERT, Olivier, FR
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SUSTAINED RELEASE FORMULATION COMPRISING A SOMATOSTATIN ANALOGUE |
| SUSTAINED RELEASE FORMULATION COMPRISING A SOMATOSTATIN ANALOGUE |